questionsmedicales.fr
Lipides
Acides gras
Acides gras volatils
Valérates
Valérates : Questions médicales fréquentes
Diagnostic
5
Analyse d'urine
Valérates
Signes cliniques
Valérates
Symptômes
5
Effets secondaires
Valérates
Réactions allergiques
Valérates
Système nerveux central
Valérates
Troubles de la mémoire
Valérates
Prévention
5
Éducation des patients
Valérates
Traitements
5
Effets secondaires
Valérates
Prescription médicale
Valérates
Complications
5
Problèmes cardiaques
Valérates
Interactions médicamenteuses
Valérates
Risques à long terme
Valérates
Facteurs de risque
5
Intoxication
Facteurs de risque
Personnes âgées
Valérates
Troubles mentaux
Valérates
Interactions médicamenteuses
Valérates
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Valérates : Questions médicales les plus fréquentes",
"headline": "Valérates : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Valérates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-19",
"dateModified": "2026-02-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Valérates"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Acides gras volatils",
"url": "https://questionsmedicales.fr/mesh/D005232",
"about": {
"@type": "MedicalCondition",
"name": "Acides gras volatils",
"code": {
"@type": "MedicalCode",
"code": "D005232",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acides pentanoïques",
"alternateName": "Pentanoic Acids",
"url": "https://questionsmedicales.fr/mesh/D010421",
"about": {
"@type": "MedicalCondition",
"name": "Acides pentanoïques",
"code": {
"@type": "MedicalCode",
"code": "D010421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.400.895.593"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gemfibrozil",
"alternateName": "Gemfibrozil",
"url": "https://questionsmedicales.fr/mesh/D015248",
"about": {
"@type": "MedicalCondition",
"name": "Gemfibrozil",
"code": {
"@type": "MedicalCode",
"code": "D015248",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.400.895.593.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acide valproïque",
"alternateName": "Valproic Acid",
"url": "https://questionsmedicales.fr/mesh/D014635",
"about": {
"@type": "MedicalCondition",
"name": "Acide valproïque",
"code": {
"@type": "MedicalCode",
"code": "D014635",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.400.895.593.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Valérates",
"alternateName": "Valerates",
"code": {
"@type": "MedicalCode",
"code": "D014631",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Oskari Heikinheimo",
"url": "https://questionsmedicales.fr/author/Oskari%20Heikinheimo",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029 Helsinki, Finland."
}
},
{
"@type": "Person",
"name": "Juha S Tapanainen",
"url": "https://questionsmedicales.fr/author/Juha%20S%20Tapanainen",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029 Helsinki, Finland."
}
},
{
"@type": "Person",
"name": "Rui Han",
"url": "https://questionsmedicales.fr/author/Rui%20Han",
"affiliation": {
"@type": "Organization",
"name": "Department of Chinese Medicine, Naval Medical University, Shanghai, 200433, People's Republic of China. dianxiqiao@foxmail.com."
}
},
{
"@type": "Person",
"name": "Annina Haverinen",
"url": "https://questionsmedicales.fr/author/Annina%20Haverinen",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029 Helsinki, Finland."
}
},
{
"@type": "Person",
"name": "Kaisu Luiro",
"url": "https://questionsmedicales.fr/author/Kaisu%20Luiro",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029 Helsinki, Finland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Biodegradable Polyhydroxyalkanoates with a Different Set of Valerate Monomers: Chemical Structure and Physicochemical Properties.",
"datePublished": "2023-09-14",
"url": "https://questionsmedicales.fr/article/37762383",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241814082"
}
},
{
"@type": "ScholarlyArticle",
"name": "Competitive Valerate Binding Enables RuO",
"datePublished": "2024-07-17",
"url": "https://questionsmedicales.fr/article/39018109",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/jacs.4c01776"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bond dissociation energies of ethyl valerate and tripropionin.",
"datePublished": "2023-07-24",
"url": "https://questionsmedicales.fr/article/37482544",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00894-023-05666-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis.",
"datePublished": "2024-01-11",
"url": "https://questionsmedicales.fr/article/38206334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/ibd/izad187"
}
},
{
"@type": "ScholarlyArticle",
"name": "Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study.",
"datePublished": "2023-08-04",
"url": "https://questionsmedicales.fr/article/37543249",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbi.2023.07.025"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides gras",
"item": "https://questionsmedicales.fr/mesh/D005227"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides gras volatils",
"item": "https://questionsmedicales.fr/mesh/D005232"
},
{
"@type": "ListItem",
"position": 5,
"name": "Valérates",
"item": "https://questionsmedicales.fr/mesh/D014631"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Valérates - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Valérates",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Valérates",
"description": "Comment diagnostiquer une intoxication aux valérates ?\nQuels tests sont utilisés pour évaluer les valérates ?\nQuels symptômes indiquent une surdose de valérates ?\nLes valérates sont-ils détectables par des tests urinaires ?\nQuels signes cliniques sont associés aux valérates ?",
"url": "https://questionsmedicales.fr/mesh/D014631#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Valérates",
"description": "Quels sont les effets secondaires courants des valérates ?\nLes valérates provoquent-ils des réactions allergiques ?\nComment les valérates affectent-ils le système nerveux ?\nQuels symptômes indiquent une dépendance aux valérates ?\nLes valérates peuvent-ils causer des troubles de la mémoire ?",
"url": "https://questionsmedicales.fr/mesh/D014631#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Valérates",
"description": "Comment prévenir une surdose de valérates ?\nQuelles précautions prendre lors de l'utilisation des valérates ?\nLes femmes enceintes peuvent-elles utiliser des valérates ?\nComment éduquer les patients sur les valérates ?\nLes valérates sont-ils sûrs pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D014631#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Valérates",
"description": "Comment traiter une intoxication aux valérates ?\nQuels antidotes existent pour les valérates ?\nLes valérates sont-ils utilisés pour l'anxiété ?\nComment réduire les effets secondaires des valérates ?\nLes valérates nécessitent-ils une prescription médicale ?",
"url": "https://questionsmedicales.fr/mesh/D014631#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Valérates",
"description": "Quelles sont les complications possibles des valérates ?\nLes valérates peuvent-ils causer des problèmes cardiaques ?\nComment les valérates affectent-ils le foie ?\nLes valérates peuvent-ils interagir avec d'autres médicaments ?\nQuels sont les risques à long terme des valérates ?",
"url": "https://questionsmedicales.fr/mesh/D014631#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Valérates",
"description": "Qui est à risque d'intoxication aux valérates ?\nLes personnes âgées sont-elles plus à risque avec les valérates ?\nQuels comportements augmentent le risque d'abus de valérates ?\nLes antécédents de troubles mentaux augmentent-ils le risque ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D014631#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux valérates ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et les symptômes cliniques observés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les valérates ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent mesurer les niveaux de valérates dans le sang."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose de valérates ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent somnolence, confusion, et dépression respiratoire."
}
},
{
"@type": "Question",
"name": "Les valérates sont-ils détectables par des tests urinaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les valérates peuvent être détectés dans les analyses d'urine."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés aux valérates ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent hypotension, bradycardie et dépression du système nerveux central."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants des valérates ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent somnolence, vertiges et troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Les valérates provoquent-ils des réactions allergiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques peuvent survenir, bien que rares."
}
},
{
"@type": "Question",
"name": "Comment les valérates affectent-ils le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils agissent comme dépresseurs du système nerveux central, induisant la relaxation."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dépendance aux valérates ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des envies intenses et des symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Les valérates peuvent-ils causer des troubles de la mémoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une utilisation prolongée peut entraîner des troubles de la mémoire."
}
},
{
"@type": "Question",
"name": "Comment prévenir une surdose de valérates ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter les doses prescrites et éviter l'automédication."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre lors de l'utilisation des valérates ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'alcool et informer le médecin des autres médicaments pris."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles utiliser des valérates ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation doit être évitée sauf si prescrite par un médecin."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les valérates ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur les effets, les doses et les risques associés à leur utilisation."
}
},
{
"@type": "Question",
"name": "Les valérates sont-ils sûrs pour les enfants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation chez les enfants doit être soigneusement évaluée par un médecin."
}
},
{
"@type": "Question",
"name": "Comment traiter une intoxication aux valérates ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut le soutien respiratoire et l'administration de charbon actif."
}
},
{
"@type": "Question",
"name": "Quels antidotes existent pour les valérates ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les valérates sont-ils utilisés pour l'anxiété ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont parfois prescrits pour traiter l'anxiété et l'insomnie."
}
},
{
"@type": "Question",
"name": "Comment réduire les effets secondaires des valérates ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Diminuer la dose ou changer de médicament peut aider à réduire les effets secondaires."
}
},
{
"@type": "Question",
"name": "Les valérates nécessitent-ils une prescription médicale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les valérates sont des médicaments soumis à prescription médicale."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des valérates ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent dépression respiratoire et coma en cas de surdose."
}
},
{
"@type": "Question",
"name": "Les valérates peuvent-ils causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner des troubles du rythme cardiaque en cas de surdose."
}
},
{
"@type": "Question",
"name": "Comment les valérates affectent-ils le foie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation excessive peut entraîner des lésions hépatiques."
}
},
{
"@type": "Question",
"name": "Les valérates peuvent-ils interagir avec d'autres médicaments ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent interagir avec d'autres dépresseurs du SNC, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme des valérates ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation prolongée peut entraîner une dépendance et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'intoxication aux valérates ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes utilisant d'autres dépresseurs du SNC ou ayant des antécédents d'abus."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque avec les valérates ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus sensibles aux effets des valérates."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'abus de valérates ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'automédication et la consommation d'alcool augmentent le risque d'abus."
}
},
{
"@type": "Question",
"name": "Les antécédents de troubles mentaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des antécédents de troubles mentaux sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les interactions avec d'autres médicaments peuvent augmenter le risque d'effets indésirables."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/02/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029 Helsinki, Finland.
Publications dans "Valérates" :
4 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029 Helsinki, Finland.
Publications dans "Valérates" :
3 publications dans cette catégorie
Affiliations :
Department of Chinese Medicine, Naval Medical University, Shanghai, 200433, People's Republic of China. dianxiqiao@foxmail.com.
Department of Chinese Medicine Oncology, Changhai Hospital affiliated to Naval Medical University, Shanghai, 200433, People's Republic of China. dianxiqiao@foxmail.com.
Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, People's Republic of China. dianxiqiao@foxmail.com.
Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT, 06520-8034, USA. dianxiqiao@foxmail.com.
School of Medicine, Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT, 06520-8034, USA. dianxiqiao@foxmail.com.
Yale Cancer Center, Yale University, 60 College Street, New Haven, CT, 06520-8034, USA. dianxiqiao@foxmail.com.
Publications dans "Valérates" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029 Helsinki, Finland.
Publications dans "Valérates" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, PO Box 140, 00029 Helsinki, Finland.
Publications dans "Valérates" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, University of Oulu, Oulu University Hospital and Medical Research Centre PEDEGO Research Unit, PO Box 5000, 90014 Oulu, Finland.
Publications dans "Valérates" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, University of Oulu, Oulu University Hospital and Medical Research Centre PEDEGO Research Unit, PO Box 5000, 90014 Oulu, Finland.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
Department of Integrated Chinese and Western Medicine & Geriatric Oncology, Peking University Cancer Hospital, Beijing, 100142, People's Republic of China.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
School of Public Health, Yale University, New Haven, CT 06520, USA.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, P. R. China.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
School of Public Health, Yale University, New Haven, CT 06520, USA.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
Department of Zoology, Ghazi University, Dera Ghazi Khan, Pakistan.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
Catalysis Science and Engineering Research Group (GICIC), Instituto de Investigaciones en Catálisis y Petroquímica (INCAPE) UNL-CONICET, Centro Científico Tecnológico. Paraje El Pozo, Santa Fe, 3000), Santa Fe, Argentina.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
Catalysis Science and Engineering Research Group (GICIC), Instituto de Investigaciones en Catálisis y Petroquímica (INCAPE) UNL-CONICET, Centro Científico Tecnológico. Paraje El Pozo, Santa Fe, 3000), Santa Fe, Argentina.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
Catalysis Science and Engineering Research Group (GICIC), Instituto de Investigaciones en Catálisis y Petroquímica (INCAPE) UNL-CONICET, Centro Científico Tecnológico. Paraje El Pozo, Santa Fe, 3000), Santa Fe, Argentina.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, School of Medicine, The University of Sydney, Sydney, New South Wales, Australia.
Heart Research Institute, The University of Sydney, Sydney, New South Wales, Australia.
Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
University of Connecticut Health Center.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
University of Connecticut Health Center.
Publications dans "Valérates" :
2 publications dans cette catégorie
Affiliations :
University of Connecticut Health Center.
Publications dans "Valérates" :
The properties, features of thermal behavior and crystallization of copolymers containing various types of valerate monomers were studied depending on the set and ratio of monomers. We synthesized and...
The (non)-Kolbe oxidation of valeric acid, sourced from a hydrolysis product of cellulose, provides a sustainable synthetic route to access value-added products, such as butene. An essential mechanist...
Due to the expected decrease in the availability of conventional oils, numerous studies are currently underway to find complementary sources of energy. Among the explored avenue is that of biofuels. E...
BDHs of ETV and TPP are computed using density functional theory (DFT) and quantum chemistry composite methods at 6-31G(d,p) and 6-311 + G(3df,2p) levels. Because of its reliability and accuracy in th...
Ulcerative colitis (UC) is characterized by a complicated interaction between mucosal inflammation, epithelial dysfunction, abnormal activation of innate immune responses, and gut microbiota dysbiosis...
Studies of human clinical specimens and experimental colitis models were conducted to confirm the pathological manifestations of the level of SCFAs from human fecal samples and murine colonic homogena...
In line with gut microbiota dysfunction in UC, alteration of SCFAs from gut microbes were identified in human UC patients and dextran sodium sulfate -induced murine colitis models. Notably, VA was con...
In summary, the research uncovered the pathological role of VA in modulating the activation of macrophages in UC and suggested that VA might be a potential effective agent for UC patients....
Fatigue among patients with head and neck cancer (HNC) has been associated with higher inflammation. Short-chain fatty acids (SCFAs) have been shown to have anti-inflammatory and immunoregulatory effe...
Beta-hydroxy-beta-methylbutyrate (HMB) is a nutrition supplement that may attenuate muscle wasting from critical illness. This trial aimed to determine feasibility of administering a blinded nutrition...
Single-center, parallel-group, blinded, placebo-controlled, randomized feasibility trial. After traumatic injury necessitating admission to ICU, participants were randomized to receive an enteral stud...
Fifty randomized participants (intervention, n = 26; placebo, n = 24) showed comparable baseline characteristics. Participants received 862 (84.3%) of the 1022 prescribed supplements during hospitaliz...
A blinded, placebo-controlled, randomized clinical trial of daily enteral HMB supplementation for up to 28 days in hospital is feasible. Any effect of HMB supplementation to attenuate muscle wasting a...
One of the key intermediates, 5-hydroxyvaleric acid (5-HV), is used in the synthesis of polyhydroxyalkanoate monomer, δ-valerolactone, 1,5-pentanediol (1,5-PDO), and many other substances. Due to glob...
Biotinidase (BTD) deficiency (OMIM 253260) is an autosomal recessively inherited metabolic disorder resulting from deficient activity of the BTD enzyme, which can cleave and release biotin from a vari...
Warfighters, often called tactical athletes, seek dietary supplementation to enhance training and recovery. Roughly 69% of active-duty US military personnel have reported consuming dietary supplements...
Randomized controlled trials and quasi-experimental controlled trials of oral dietary supplementation in active-duty military members were examined. A protocol was registered (PROSPERO CRD42023401472)...
Sixteen studies were included. Four were conducted on protein or carbohydrate; four on beta-alanine alone, creatine alone, or in combination; two on mixed nutritional supplements; two on probiotics al...
Nutrition supplementation may have small benefits on muscle performance and recovery in warfighters. However, there are significant limitations in interpretation due to the largely inconsistent eviden...
Hip fractures are prevalent among older people, often leading to reduced mobility, muscle loss, and bone density decline. Malnutrition exacerbates the prognosis post surgery. This study aimed to evalu...
A total of 270 subjects ≥75 years of age, residing at home or in nursing homes, malnourished or at risk of malnutrition, and post hip fracture surgery, received HC-HP-HMB-ONS for 12 weeks. Various sca...
During the 12 weeks of follow-up, 82.8% consumed ≥75% of HC-HP-HMB-ONS. By week 12, 62.4% gained or maintained weight (+0.3 kg), 29.2% achieved normal nutritional status (mean MNA score +2.8), and 46....
The administration of HC-HP-HMB-ONS markedly enhanced nutritional status and biochemical parameters in older hip-fracture patients, with high compliance and tolerability. Both patients and healthcare ...